Institute for Regenerative Medicine (IREM), University of Zurich Campus Schlieren, Wagistrasse 12, CH-8952 Schlieren, Switzerland.
Biol Chem. 2020 Dec 2;402(4):481-499. doi: 10.1515/hsz-2020-0279. Print 2021 Mar 26.
Proteolytic processing of the amyloid precursor protein (APP) releases the APP intracellular domain (AICD) from the membrane. Bound to the APP adaptor protein Fe65 and the lysine acetyltransferase (KAT) Tip60, AICD translocates to the nucleus. Here, the complex forms spherical condensates at sites of endogenous target genes, termed AFT spots (ICD-e65-ip60). We show that loss of Tip60 KAT activity prevents autoacetylation, reduces binding of Fe65 and abolishes Fe65-mediated stabilization of Tip60. Autoacetylation is a prerequisite for AFT spot formation, with KAT-deficient Tip60 retained together with Fe65 in speckles. We identify lysine residues 204 and 701 of Fe65 as acetylation targets of Tip60. We do not detect acetylation of AICD. Mutation of Fe65 K204 and K701 to glutamine, mimicking acetylation-induced charge neutralization, increases the transcriptional activity of Fe65 whereas Tip60 inhibition reduces it. The lysine deacetylase (KDAC) class III Sirt1 deacetylates Fe65 and pharmacological modulation of Sirt1 activity regulates Fe65 transcriptional activity. A second acetylation/deacetylation cycle, conducted by CBP and class I/II KDACs at different lysine residues, regulates stability of Fe65. This is the first report describing a role for acetylation in the regulation of Fe65 transcriptional activity, with Tip60 being the only KAT tested that supports AFT spot formation.
蛋白水解处理淀粉样前体蛋白(APP)将 APP 细胞内结构域(AICD)从膜上释放出来。与 APP 衔接蛋白 Fe65 和赖氨酸乙酰转移酶(KAT)Tip60 结合后,AICD 易位到细胞核。在那里,该复合物在称为 AFT 斑点(ICD-e65-ip60)的内源性靶基因部位形成球形凝聚物。我们发现,Tip60 KAT 活性的丧失阻止了自身乙酰化,降低了 Fe65 的结合,并消除了 Fe65 介导的 Tip60 稳定作用。自身乙酰化是 AFT 斑点形成的前提,缺乏 KAT 的 Tip60 与 Fe65 一起保留在斑点中。我们确定了 Fe65 的赖氨酸残基 204 和 701 是 Tip60 的乙酰化靶标。我们没有检测到 AICD 的乙酰化。Fe65 的 K204 和 K701 突变为谷氨酰胺,模拟了乙酰化诱导的电荷中和,增加了 Fe65 的转录活性,而 Tip60 抑制则降低了它。赖氨酸去乙酰化酶(KDAC)III 类 Sirt1 去乙酰化 Fe65,药理学调节 Sirt1 活性调节 Fe65 的转录活性。第二个乙酰化/去乙酰化循环由 CBP 和不同赖氨酸残基的 I 类/II 类 KDACs 进行,调节 Fe65 的稳定性。这是第一个描述乙酰化在调节 Fe65 转录活性中的作用的报告,Tip60 是唯一被测试支持 AFT 斑点形成的 KAT。